ישראל - עברית - Ministry of Health

bayer israel ltd - moxifloxacin as hydrochloride - תמיסה לאינפוזיה - moxifloxacin as hydrochloride 1.6 mg/ml - moxifloxacin - moxifloxacin - megaxin iv is indicated for the treatment of adults (> 18 years of age) with community acuired pneumonia caused by streptococcus pneumoniae, haemophilus influenzae, moraxella catarrhalis, staphylococcus aureus, klebsiella pneumoniae, mycoplasma pneumoniae or chlamydia pneumoniae and complicated skin and skin structure infections caused by methicillin susceptible staphylococus aureus, escherichia coli, klebsiella pneumoniae or enterobacter cloacae. appropriate culture and susceptibility tests should be performed before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to moxifloxacin. therapy with megaxin may be initiated before results of these tests are known; once results become available ,appropriate therapy should be continued.

ישראל - עברית - Ministry of Health

novartis israel ltd - moxifloxacin as hydrochloride - תמיסה לעין - moxifloxacin as hydrochloride 0.5 % - moxifloxacin - moxifloxacin - for the treatment of bacterial conjunctivitis caused by susceptible strains or organisms.

ישראל - עברית - Ministry of Health

bayer israel ltd - moxifloxacin as hydrochloride - טבליות מצופות פילם - moxifloxacin as hydrochloride 0.4 g - moxifloxacin - moxifloxacin - for the treatment of the following bacterial infections: respiratory infections: bronchitis: acute exacerbation of chronic bronchitis ; pneumonia: community acquired ; sinusitis: acute uncomplicated; community-acquired spontaneous and wound infections of the skin and skin structure.

ישראל - עברית - Ministry of Health

bayer israel ltd - moxifloxacin as hydrochloride - טבליות מצופות פילם - moxifloxacin as hydrochloride 0.4 g - moxifloxacin - moxifloxacin - for the treatment of the following bacterial infections: respiratory infections: bronchitis: acute exacerbation of chronic bronchitis ; pneumonia: community acquired ; sinusitis: acute uncomplicated; community-acquired spontaneous and wound infections of the skin and skin structure.

ישראל - עברית - Ministry of Health

bayer israel ltd - moxifloxacin - תמיסה לאינפוזיה - moxifloxacin 400 mg / 250 ml - moxifloxacin - moxifloxacin - megaxin iv is indicated for the treatment of adults (> 18 years of age) with community acuired pneumonia caused by streptococcus pneumoniae, haemophilus influenzae, moraxella catarrhalis, staphylococcus aureus, klebsiella pneumoniae, mycoplasma pneumoniae or chlamydia pneumoniae and complicated skin and skin structure infections caused by methicillin susceptible staphylococus aureus, escherichia coli, klebsiella pneumoniae or enterobacter cloacae. appropriate culture and susceptibility tests should be performed before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to moxifloxacin. therapy with megaxin may be initiated before results of these tests are known; once results become available ,appropriate therapy should be continued.

ישראל - עברית - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - moxifloxacin as hydrochloride - טיפות עיניים - moxifloxacin as hydrochloride 0.5 %w/v - moxifloxacin

ישראל - עברית - Ministry of Health

biovac ltd., israel - norfloxacin - תמיסה (פומי) - norfloxacin 20 %

ישראל - עברית - Ministry of Health

intervet ( israel) ltd - mometasone furoate (as monohydrate); orbifloxacin; posaconazole - orbifloxacin 8.5 mg/ml; mometasone furoate (as monohydrate) 0.9 mg/ml; posaconazole 0.9 mg/ml

ישראל - עברית - Ministry of Health

allergan israel ltd - gatifloxacin 3 mg/ml - ophthalmic solution - gatifloxacin - zymar is indicated for the treatment of bacterial conjunctivitis caused by suspectible strains of the following organisms : aerobic gram - positive bacteria : cornyebacterium propinquum - staphylococcus aureus - staphylococcus epidermidis - streptococcus mitis - streptococcus pneumoniae. aerobic gram - negative bacteria : - haemophilus influenza. - efficacy for this organisms was studied in fewer than 10 infections.

ישראל - עברית - Ministry of Health

allergan israel ltd - gatifloxacin 0.5 %w/v - ophthalmic solution - gatifloxacin - zymaxid is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms: aerobic gram- negative bacteria : haemophilus influenzae, aerobic gram-positive bacteria: staphylococcus aureus, staphylococcus epidermidis, streptococcus mitis group*, streptococcus oralis *, streptococcus pneumoniae. efficacy for this organisms was studied in fewer than 10 infections.